WallStSmart
ZURA

Zura Bio Limited Class A Ordinary Shares

NASDAQ: ZURA · HEALTHCARE · BIOTECHNOLOGY

$5.08
+1.40% today

Updated 2026-04-30

Market cap
$502.87M
P/E ratio
P/S ratio
EPS (TTM)
$-1.06
Dividend yield
52W range
$1 – $7
Volume
0.6M

Zura Bio Limited Class A Ordinary Shares (ZURA) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-19.3%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-390.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-10.4%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-11.9%
2025-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-20$-0.49-226.7%$6.12$5.57-9.0%
2025-11-13$-0.17+45.2%$4.63$4.08-11.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.15$-0.49-226.7%
2025-09-30$-0.31$-0.17+45.2%
2025-06-30$-0.30$-0.17+43.3%
2025-03-31$-0.29$-0.19+34.5%
2024-12-31$-0.24$-0.10+58.3%$2000.00
2024-09-30$-0.13$-0.26-100.0%
2024-06-30$-0.15$-0.17-13.3%
2024-03-31$-0.23$-0.02+91.3%
2023-12-31$-0.23$-0.19+17.4%
2023-09-30$-0.25$-0.18+28.0%
2023-06-30$-0.25$-1.31-424.0%
2023-03-31$-2.76

Frequently asked questions

Has Zura Bio Limited Class A Ordinary Shares beaten earnings estimates?
Zura Bio Limited Class A Ordinary Shares has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -19.3% over the last 4 quarters.
How does ZURA stock react to earnings?
ZURA stock has moved an average of -10.4% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.